HomeInsightsStock Comparison

Dishman Carbogen Amcis Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Dishman Carbogen Amcis Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Dishman Carbogen Amcis Ltd is ₹ 244.85 as of 01 Aug 15:30.
  • The P/E Ratio of Dishman Carbogen Amcis Ltd changed from 5.3 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 32.6 on March 2020 to 57.3 on March 2025 . This represents a CAGR of 9.86% over 6 years.
  • The Market Cap of Dishman Carbogen Amcis Ltd changed from ₹ 840.79 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 33361 crore on March 2020 to ₹ 109468 crore on March 2025 . This represents a CAGR of 21.90% over 6 years.
  • The revenue of Dishman Carbogen Amcis Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 724.31 crore. This represent the decline of -100% The revenue of Torrent Pharmaceuticals Ltd for the Jun '25 is ₹ 3141 crore as compare to the Mar '25 revenue of ₹ 2941 crore. This represent the growth of 6.8%.
  • The ebitda of Dishman Carbogen Amcis Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 148.91 crore. This represent the decline of -100% The ebitda of Torrent Pharmaceuticals Ltd for the Jun '25 is ₹ 995 crore as compare to the Mar '25 ebitda of ₹ 922 crore. This represent the growth of 7.92%.
  • The net profit of Dishman Carbogen Amcis Ltd changed from ₹ 17 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 378 crore to ₹ 548 crore over 9 quarters. This represents a CAGR of 17.95% .
  • The Dividend Payout of Dishman Carbogen Amcis Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 57.71 % on March 2020 to 10.76 % on March 2025 . This represents a CAGR of -24.42% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dishman Carbogen Amcis Ltd

  • Dishman Carbogen Amcis Limited was formerly incorporated as 'Carbogen Amcis (India) Limited' on July 17, 2007.
  • The Company name later on, was changed to 'Dishman Carbogen Amcis Limited' on 27 March 2017.
  • The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants.
  • It works manufacturing and research facilities in India, Switzerland, France, The Netherland and China. During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCL's subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure.
  • The name of Carbogen Amcis (India) Ltd.

About Torrent Pharmaceuticals Ltd

  • Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
  • The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
  • The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
  • It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 15 countries with major setups in the US, Germany and Brazil.

Dishman Carbogen Amcis Ltd News Hub

News

Dishman Carbogen Amcis' Ahmedabad facility clears USFDA inspection without observations

The inspection was conducted from 9 June to 13 June 2025. According to the company's state...

Read more

16 Jun 2025 12:15

News

Carbogen Amic AG to co-invest in its manufacturing sites in Switzerland

Dishman Carbogen Amcis' wholly owned subsidiary, CARBOGEN AMCIS AG, a pharmaceutical proce...

Read more

06 Jun 2025 18:05

News

Dishman Carbogen spurts after turnaround Q4 outcome

Consolidated net sales rose 9.41% year-on-year to Rs 716.34 crore in Q4 March 2025. Pre-ta...

Read more

22 May 2025 12:16

News

Dishman Carbogen Amcis to hold board meeting

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 21 ...

Read more

17 May 2025 14:39

News

Dishman Carbogen Amcis' Shanghai facility clears China regulatory compliance

Dishman Carbogen Amcis announced that its Shanghai facility has successfully obtained its ...

Read more

21 Apr 2025 19:33

News

Dishman Carbogen Amcis receives affirmation in credit ratings

Dishman Carbogen Amcis has received affirmation in credit ratings from India Ratings and R...

Read more

16 Apr 2025 19:56

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharma gains as Q1 earnings impress; foreign broker hikes target

The pharma major reported a net profit of Rs 548 crore, marking a 20% year-on-year increas...

Read more

29 Jul 2025 10:36

News

Torrent Pharmaceuticals Ltd gains for third straight session

Torrent Pharmaceuticals Ltd is up for a third straight session today. The stock is quoting...

Read more

29 Jul 2025 13:05

News

Board of Torrent Pharmaceuticals approves issuance of NCDs/ bonds

The Board of Torrent Pharmaceuticals at its meeting held on 28 July 2025 has approved the ...

Read more

28 Jul 2025 16:32

News

Torrent Pharmaceuticals to hold board meeting

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28...

Read more

22 Jul 2025 10:21

News

Torrent Pharmaceuticals Ltd gains for fifth session

Torrent Pharmaceuticals Ltd is up for a fifth straight session in a row. The stock is quot...

Read more

18 Jul 2025 13:00

News

Torrent Pharmaceuticals AGM scheduled

Torrent Pharmaceuticals announced that the 52th Annual General Meeting(AGM) of the company...

Read more

05 Jul 2025 17:16

SWOT Analysis Of Torrent Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Dishman Carbogen Amcis Ltd

Strength

1

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Dishman Carbogen Amcis Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Torrent Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dishman Carbogen Amcis Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Dishman Carbogen Amcis Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Dishman Carbogen Amcis Ltd is 3,838 Cr while Market cap of Torrent Pharmaceuticals Ltd is 124,346 Cr

What are the key factors driving the stock performance of Dishman Carbogen Amcis Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Dishman Carbogen Amcis Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dishman Carbogen Amcis Ltd and Torrent Pharmaceuticals Ltd?

As of August 2, 2025, the Dishman Carbogen Amcis Ltd stock price is INR ₹244.85. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹3674.2.

How do dividend payouts of Dishman Carbogen Amcis Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Dishman Carbogen Amcis Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions